GoodRx Holdings, Inc.·4

Mar 1, 4:33 PM ET

Bezdek Trevor 4

4 · GoodRx Holdings, Inc. · Filed Mar 1, 2024

Insider Transaction Report

Form 4
Period: 2024-03-01
Transactions
  • Exercise/Conversion

    Class B Common Stock

    2024-03-01+256,595256,595 total
    Class A Common Stock (256,595 underlying)
  • Conversion

    Class A Common Stock

    2024-03-01+145,2585,138,890 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-03-01256,595513,189 total
    Class B Common Stock (256,595 underlying)
  • Tax Payment

    Class B Common Stock

    2024-03-01$7.79/sh111,337$867,315145,258 total
    Class A Common Stock (111,337 underlying)
  • Conversion

    Class B Common Stock

    2024-03-01145,2580 total
    Class A Common Stock (145,258 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class B common stock.
  • [F2]The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020.
  • [F3]Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.

Documents

1 file
  • 4
    wk-form4_1709328779.xmlPrimary

    FORM 4